Literature DB >> 2901128

Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats.

R Dall'Olio1, O Gandolfi, A Vaccheri, P Roncada, N Montanaro.   

Abstract

The selective D1 receptor stimulant SKF 38393 dose-dependently increased grooming time in rats without affecting locomotor activity or eliciting stereotyped behaviour. The selective D2 receptor agonist LY 171555 induced a dose-dependent increase in rat motility, a marked decrease in grooming time and a low occurrence of stereotyped behaviour. Concurrent administration of the two selective agonists induced high-degree stereotyped responses and reductions in locomotor and grooming behaviours. Rats withdrawn from repeated treatment with the selective D1 receptor blocker SCH 23390 (0.05 mg/kg twice daily for 21 days; 7 days of washout) did not exhibit any change of locomotor and grooming responses to threshold doses of LY 171555 and SKF 38393 given alone or in combination. On the contrary, a significantly greater occurrence of high-degree stereotyped responses to the combination of the two selective agonists was observed. The data support the view that D1 and D2 receptors have a cooperative role in the generation of stereotypies and suggest that D1 receptor supersensitivity needs D2 stimulation to be revealed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901128     DOI: 10.1007/bf00181952

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

1.  Responses to selective D-1 and D-2 agonists after repeated treatment with selective D-1 and D-2 antagonists.

Authors:  O Gandolfi; R Dall'olio; A Vaccheri; P Roncada; N Montanaro
Journal:  Pharmacol Biochem Behav       Date:  1988-06       Impact factor: 3.533

2.  Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.

Authors:  J Arnt; J Hyttel; J Perregaard
Journal:  Eur J Pharmacol       Date:  1987-01-13       Impact factor: 4.432

3.  Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats.

Authors:  A M Ernst
Journal:  Psychopharmacologia       Date:  1967

4.  Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393.

Authors:  M Mashurano; J L Waddington
Journal:  Neuropharmacology       Date:  1986-08       Impact factor: 5.250

5.  Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.

Authors:  A R Braun; T N Chase
Journal:  Eur J Pharmacol       Date:  1986-11-19       Impact factor: 4.432

6.  Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390.

Authors:  I Creese; A Chen
Journal:  Eur J Pharmacol       Date:  1985-02-12       Impact factor: 4.432

7.  Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.

Authors:  G R Breese; R A Mueller
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

9.  Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390.

Authors:  A Vaccheri; R Dall'Olio; O Gandolfi; P Roncada; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions.

Authors:  P Barone; T A Davis; A R Braun; T N Chase
Journal:  Eur J Pharmacol       Date:  1986-04-09       Impact factor: 4.432

  10 in total
  11 in total

1.  Psychopharmacological responsiveness to the dopamine agonist quinpirole in normal weanlings and in weanling offspring exposed gestationally to cocaine.

Authors:  C A Moody; N A Frambes; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Ontogenetic differences in the psychopharmacological responses to separate and combined stimulation of D1 and D2 dopamine receptors during the neonatal to weanling age period.

Authors:  C A Moody; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets.

Authors:  P A Löschmann; L A Smith; K W Lange; P Jaehnig; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Synergistic blockade of some dopamine-mediated behaviours by (-)-sulpiride and SCH 23390 in the rat.

Authors:  R Dall'Olio; P Roncada; A Vaccheri; O Gandolfi; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity.

Authors:  A Plaznik; R Stefanski; W Kostowski
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Behavioral effects of selective and nonselective dopamine agonists on young rats after irreversible antagonism of D1 and/or D2 receptors.

Authors:  S A McDougall; C A Crawford; A J Nonneman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.

Authors:  R Dall'Olio; R Rimondini; O Gandolfi
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

8.  Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.

Authors:  C A Moody; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease.

Authors:  K K Gnanalingham; A J Hunter; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

10.  Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.

Authors:  Tina Scardochio; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.